Scilex Holding (SCLXW) Prepaid Assets (2021 - 2026)
Scilex Holding (SCLXW) recorded quarterly Prepaid Assets of $4.2 million in Q1 2026, down 42.4% quarter-over-quarter from $7.3 million in Q4 2025, and down 54.36% on a YoY basis from $9.3 million in Q1 2025.
Scilex Holding (SCLXW) Prepaid Assets (2021 - 2026) Analysis & Trends
Scilex Holding's Prepaid Assets history runs 6 years deep, the most recent figure standing at $4.2 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 54.36% year-over-year to $4.2 million; the TTM figure through Mar 2026 stood at $4.2 million (down 54.36% YoY), while the FY2025 annual figure was $7.3 million, down 21.85% from the prior year.
- Prepaid Assets was $4.2 million for Q1 2026 at Scilex Holding, down from $7.3 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $10.3 million in Q2 2025 to a low of $130788.0 in Q3 2022.
- Historically, Prepaid Assets has averaged $4.5 million across 5 years, with a median of $4.2 million in 2026.
- The sharpest annual moves came in 2023 and 2025: Prepaid Assets surged 2313.83% in 2023, then tumbled 55.37% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $4.8 million in 2022, then declined by 15.82% to $4.0 million in 2023, then surged by 132.08% to $9.4 million in 2024, then decreased by 21.85% to $7.3 million in 2025, then plunged by 42.4% to $4.2 million in 2026.
- The last three Prepaid Assets figures came in at $4.2 million (Q1 2026), $7.3 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn |
| 10 | Scilex Holding | - | - | 4.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.23 Mn |
| Dec 31, 2025 | 7.34 Mn |
| Sep 30, 2025 | 2.59 Mn |
| Jun 30, 2025 | 10.29 Mn |
| Mar 31, 2025 | 9.27 Mn |
| Dec 31, 2024 | 9.40 Mn |
| Sep 30, 2024 | 5.79 Mn |
| Jun 30, 2024 | 2.45 Mn |
| Mar 31, 2024 | 2.73 Mn |
| Dec 31, 2023 | 4.05 Mn |
| Sep 30, 2023 | 3.16 Mn |
| Jun 30, 2023 | 4.45 Mn |
| Mar 31, 2023 | 4.52 Mn |
| Dec 31, 2022 | 4.81 Mn |
| Sep 30, 2022 | 130,788.00 |
| Jun 30, 2022 | 261,576.00 |
| Mar 31, 2022 | 396,901.00 |
| Dec 31, 2021 | 1.84 Mn |
| Sep 30, 2021 | 116,536.00 |
| Jun 30, 2021 | 234,359.00 |